Maresins Pharma, inc.

$83,372.00 CAD

≈ 13 months of average Canadian pay

Department: National Research Council Canada
Program: Industrial Research Assistance Program – Contributions to Firms
Recipient country: Canada
Fiscal year: 2019-2020
Agreement period: October 15, 2019 – December 31, 2020
Reference: nrc-cnrc:172-2019-2020-Q3-936187

Published purpose

Several published studies have shown the high potency of MaR1 to decrease pain and inflammation in various animal models. The goal of the current project is to demonstrate and improve the capacity of a specific topical formulation containing a synthetic analog of MaR1 to decrease pain and inflammation in a relevant rodent model of vulvodynia.

Community tags

Tags are applied by readers, not by this site. One tag per person per record.

Good value Local impact Needs context Questionable Success story Wasteful

View official source record Imported August 3, 2026 from open.canada.ca Grants & Contributions